{
    "article_link": "https://doi.org/10.1038/s41467-023-42565-z",
    "data": [
        {
            "id": "data_1",
            "omics": "Epigenomics (Chromatin Accessibility)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human",
            "format": "BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_2",
            "omics": "Genomics (Whole Genome Sequencing)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human",
            "format": "BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA005668"
        },
        {
            "id": "data_3",
            "omics": "Transcriptomics (RNA-seq)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human",
            "format": "BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA000119"
        },
        {
            "id": "data_4",
            "omics": "Epigenomics (H3K27ac ChIP-seq)",
            "link": "https://ngdc.cncb.ac.cn/gsa-human",
            "format": "BAM",
            "source": "Genome Sequence Archive for Human (GSA-human)",
            "public_id": "HRA002815"
        },
        {
            "id": "data_5",
            "omics": "Epigenomics (ATAC-seq)",
            "link": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE122989",
            "format": "FASTQ",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE122989"
        },
        {
            "id": "data_6",
            "omics": "Transcriptomics (RNA-seq)",
            "link": "https://gdc.cancer.gov/about-data/publications#/?groups=TARGET-ALL-P2",
            "format": "Processed Data",
            "source": "dbGaP",
            "public_id": "phs000464"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Chromatin Accessibility Landscape Comparison",
            "analysis_data": [
                "data_1",
                "data_5"
            ],
            "label": {
                "Comparison": [
                    "B-ALL",
                    "B-cell progenitors"
                ]
            }
        },
        {
            "id": "analysis_2",
            "analysis_name": "Differential Chromatin Accessibility Analysis",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "Condition": [
                    "Diagnosis",
                    "Relapse"
                ]
            }
        },
        {
            "id": "analysis_3",
            "analysis_name": "Subtype-Specific Chromatin Accessibility Analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "Subtype": [
                    "ETV6::RUNX1",
                    "Hyperdiploidy",
                    "TCF3::PBX1",
                    "KMT2A",
                    "BCR::ABL1",
                    "BCR::ABL1-like",
                    "ZNF384",
                    "PAX5alt",
                    "TCF3::HLF",
                    "Hypodiploidy",
                    "MEF2D",
                    "B-other"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Allele-Specific Open Chromatin Analysis",
            "analysis_data": [
                "data_1",
                "data_2"
            ],
            "label": {
                "Allele": [
                    "ASOC",
                    "BiOC"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Survival Analysis",
            "analysis_data": [
                "data_1",
                "data_6"
            ],
            "label": {
                "Survival Status": [
                    "Relapse-Free Survival (RFS)",
                    "Overall Survival (OS)"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Drug Response Association Analysis",
            "analysis_data": [
                "data_1",
                "data_3"
            ],
            "label": {
                "Drug": [
                    "Cyclophosphamide",
                    "Cytarabine",
                    "Dasatinib",
                    "Dexamethasone",
                    "Doxorubicin",
                    "Etoposide",
                    "Imatinib",
                    "Methotrexate"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_1",
            "metrics": "Percentage",
            "value": "27.95% of ACRs in Quies regions",
            "features": [
                "IL7R",
                "MYC",
                "TCF3",
                "RHOA",
                "ELL"
            ]
        },
        {
            "analysis_id": "analysis_2",
            "metrics": "Number of ACRs",
            "value": "5911 relapse-high ACRs and 1423 relapse-low ACRs",
            "features": [
                "Cell adhesion-related genes",
                "Drug resistance genes"
            ]
        },
        {
            "analysis_id": "analysis_3",
            "metrics": "Subtype-Specific ACRs",
            "value": "17,981 subtype-specific ACRs identified",
            "features": [
                "E2F6",
                "RUNX3",
                "BCL2L11",
                "MECOM",
                "HOXA9"
            ]
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "Allele Imbalance",
            "value": "46 leukemia-related SNPs with imbalanced chromatin accessibility",
            "features": [
                "rs7090445",
                "rs13401811",
                "ARID5B",
                "BCL2L11"
            ]
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "Survival Probability",
            "value": "p = 3.778e−10 for RFS and p = 5.585e−7 for OS",
            "features": [
                "Hyperdiploidy cases with inferior RFS",
                "Stem cell/myeloid progenitor-like genes"
            ]
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "Fisher’s Exact Test p-value",
            "value": "p = 0.0029 (Imatinib), p = 0.0184 (Etoposide), p = 0.0047 (Dasatinib), p = 0.0167 (Doxorubicin)",
            "features": [
                "Imatinib",
                "Etoposide",
                "Doxorubicin",
                "Dasatinib"
            ]
        }
    ]
}